You are here: Industry Insights > Zika virus

News List

Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
Enesi Pharma to develop Zika virus vaccine in partnership with University of Adelaide expresspharma
September 07, 2020
It will be in a thermostable, solid dose implant format for transcutaneous delivery via a needle-free device to prevent infection of pregnant women and the resultant congenital effects in the unborn child.
Marmosets viable in vivo models for developing immune-based therapies biospectrumasia
November 27, 2018
Due to close physiological replication of infectious disease pathology in humans and lower husbandry costs compared to traditional models of larger primates.
Using Zika virus to treat neuroblastoma in children fiercepharma
July 30, 2018
Zika virus is notorious for causing brain defects when passed down from a pregnant woman to her fetus. But researchers at Nemours Children’s Hospital and the University of Central Florida suggest that ....
Blockbuster ZIKV Drug Research Published on Nature, Review of ZIKV Vaccines en-cphi.cn
August 11, 2017
Zika virus (ZIKV) spread rapidly worldwide since its outbreak in May 2015 and was listed as a “public health emergency of international concern” by WHO.
Cancer Research UK funded scientists to test Zika virus on brain tumours pharmaceutical-technology
May 27, 2017
Scientists funded by Cancer Research UK will investigate the effectiveness of the Zika virus in destroying brain tumour cells, which could lead to new treatments for cancer.
Brazil declares end to Zika virus emergency pharmafile
May 15, 2017
Brazil has declared that the national emergency over the Zika virus threat is over, after there was a 95% drop in the number of reported cases between January and April.
Zika Risk May Be Lower Than Thought for Some Pregnant Women drugs.com
May 10, 2017
U.S. women traveling to areas where the Zika virus is circulating might be less likely to be infected than expected, but risk remains, a new study suggests.
FDA Grants Nanobiosym Diagnostics Emergency Use Authorization for Gene-RADAR® Zika Virus Test americanpharmaceuticalreview
April 12, 2017
Nanobiosym Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Gene-RADAR® Zika Virus Test.
Human antibody for Zika virus promising for treatment, prevention worldpharmanews
March 17, 2017
Researchers have determined the structure of a human antibody bound to the Zika virus, revealing details about how the antibody interferes with the infection mechanism - findings that could aid in development of antiviral medications.

Previous page 1 2 Next page